Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Krejbjerg Motavaf

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|June 23, 2025
ABCG2 protein expression in tumors of patients with non-resectable pancreatic cancer treated with gemcitabine and <i>nab</i>-paclitaxelSusy Shim, Mette Bak Nielsen, Mikkel Eld, et al.
Acta Oncologica (Stockholm, Sweden)|January 12, 2026
Characteristics, treatment, and outcome of recurrent gastro-oesophageal adeno-carcinoma after perioperative chemotherapy and radical resectionAnders Christian Larsen, Susy Shim, Lene Bæksgaard, et al.
Ugeskrift for Laeger|April 16, 2013
[Changes in thyroid disease in Denmark]Peter Laurberg, Stine Linding Andersen, Anne Krejbjerg Motavaf, et al.
Translational Oncology|March 20, 2026
Exploring survival-associated transcriptomic subtypes in ovarian cancer using RNAseq from FFPE tissues in a clinical trial cohortMaj K Kjeldsen, Frederik Otzen Bagger, Henrik Roed, et al.
Cancer Research Communications|November 26, 2024
Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian CancerMaj K Kjeldsen, Morten Jørgensen, Dina Sofie B Grønseth, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|June 23, 2025
ABCG2 protein expression in tumors of patients with non-resectable pancreatic cancer treated with gemcitabine and <i>nab</i>-paclitaxelSusy Shim, Mette Bak Nielsen, Mikkel Eld, et al.
Acta Oncologica (Stockholm, Sweden)|January 12, 2026
Characteristics, treatment, and outcome of recurrent gastro-oesophageal adeno-carcinoma after perioperative chemotherapy and radical resectionAnders Christian Larsen, Susy Shim, Lene Bæksgaard, et al.
Ugeskrift for Laeger|April 16, 2013
[Changes in thyroid disease in Denmark]Peter Laurberg, Stine Linding Andersen, Anne Krejbjerg Motavaf, et al.
Translational Oncology|March 20, 2026
Exploring survival-associated transcriptomic subtypes in ovarian cancer using RNAseq from FFPE tissues in a clinical trial cohortMaj K Kjeldsen, Frederik Otzen Bagger, Henrik Roed, et al.
Cancer Research Communications|November 26, 2024
Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian CancerMaj K Kjeldsen, Morten Jørgensen, Dina Sofie B Grønseth, et al.
Pageof 1